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The “common sense” intervention by toxicology journal editors regarding proposed European Union endocrine
disrupter regulations ignores scientific evidence and well-established principles of chemical risk assessment. In this
commentary, endocrine disrupter experts express their concerns about a recently published, and is in our
considered opinion inaccurate and factually incorrect, editorial that has appeared in several journals in toxicology.
Some of the shortcomings of the editorial are discussed in detail. We call for a better founded scientific debate
which may help to overcome a polarisation of views detrimental to reaching a consensus about scientific
foundations for endocrine disrupter regulation in the EU.
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“Common sense is the collection of prejudices acquired
by age eighteen”
- Albert Einstein
As experts and practitioners of endocrine disrupter re-
search, several of whom were invited to prepare some
recent international status reports of the topic [1-4], we, the
authors, would like to comment on the recent editorial
“Scientifically unfounded precaution drives European Com-
mission’s recommendations on EDC regulation, while defy-
ing common sense, well-established science and risk
assessment principles” by Dietrich et al. [5].* Correspondence: Ake.Bergman@mmk.su.se
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reproduction in any medium, provided the orWe are concerned that the Dietrich editorial appears
to be intended as an intervention designed to impact
imminent decisions by the European Commission con-
cerning endocrine disrupting chemicals (EDCs), countering
the views recently expressed by the 129 signatories of the
Berlaymont Declaration on endocrine disrupters [6] and
by the Collegium Ramazzini [7]. Given the prominent
nature of the authors as members of several EU scientific
committees and the importance of these decisions, we
would have expected a more accurate analysis of the situ-
ation. In contrast, the editorial confuses and conflates sev-
eral aspects of the current debate that are important to
clarify. In general, their fears appear to be founded on a
‘common sense’ that largely ignores the continued efforts
of many scientific expert groups at European and inter-
national level as well as the expertise and competence of
European decision makers.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a fundamental role in the physiological response to
changes in the environment with the aim of keeping an
organism’s response within the homeostatic space” Die-
trich et al. seek to define the endocrine system in overly
simplistic terms to reduce the task of identifying endo-
crine disruption to making distinctions “between those
effects that are within this adaptive range and effects
that go beyond the boundaries of this space and thus
can be called adverse” [5]. It is perplexing that editors of
international toxicology journals seem to be unaware of
the fact that endocrine systems also have a programming
role during development, and that disruption of these
programming events leads to irreversible effects that go
far beyond disturbances of homeostasis [1]. Such phe-
nomena (for example disruption of androgen action in
fetal life and the malformations that arise from this) have
been described for decades in the scientific literature
and provide some of the cause for concerns about
endocrine disrupting chemicals. These and other
clearly demonstrated cases necessitate the identification
of specific windows of vulnerability and this poses con-
siderable challenges to established toxicity testing par-
adigms, all of which Dietrich et al. [5] ignore.
Thresholds and no thresholds
Dietrich et al. [5] claim that the “currently drafted EU
framework” is based on an a priori default assumption
of no thresholds for regulating endocrine disrupters, but
no document is referenced to substantiate this claim.
The latest publicly available document from the Euro-
pean Commission is the Report of the Endocrine Dis-
rupters Expert Advisory Group (ED EAG) published by
Directorate General Joint Research Centre (JRC) [8]
which is intended to provide the underpinnings of the
future EU regulatory framework for endocrine dis-
rupters. The Report was prepared by an expert group
comprised of 43 members from competent authorities
representing 19 member countries of the European
Union as well as other stakeholders including environ-
ment and health, NGOs and the industry-funded scien-
tific association, ECETOC. The circumstances that led
up to this Report are at odds with the claim by Dietrich
et al. [5] that the proposed regulatory framework “is
based on virtually complete ignorance of all well-
established and taught principles of toxicology and
pharmacology, of opinions raised by the European Com-
mission’s own competent expert authority (…), and of
critical statements made by EU member states…”. In the
JRC document [8], no reference is made to a presumed
a priori assumption of no thresholds for endocrine
disrupters.
From a scientific standpoint, the issue of the existence
of a threshold for endocrine disrupters and other non-genotoxic toxicants remains under debate. As Dietrich
et al. [5] rightly point out, absence of effect cannot be
statistically demonstrated in an experimental setting. It
derives from this that regardless of the mode-of-action
and the existence or non-existence of a mechanistic
threshold, such a threshold cannot be demonstrated ex-
perimentally. If science prides itself in the robustness of
its experimental approach to evidence, it should be
stressed that the current argument can be modelled or
theorised upon, but cannot currently be definitively ex-
perimentally tested. Regarding the claim that “…the
weight of evidence (…) clearly demonstrates the pres-
ence of threshold for non-genotoxic compounds includ-
ing EDCs…”, Dietrich et al. [5] ignore that this evidence
is far from established. In international toxicology
journals, not under the editorship of Dietrich et al. [5],
widely accepted biometrical and mathematical principles
about the impossibility of establishing thresholds at the
level of populations, independent of the status of the
chemicals in terms of genotoxicity or non-genotoxicity
have been elaborated [9,10].
Adversity of effects
It is also unclear where the claim by Dietrich et al. [5]
that “the currently drafted EU framework for EDCs fore-
sees a priori regulation of agents that may show presum-
ably endocrine-mediated effects in some experimental
system (in vitro, in silico, in vivo…)” derives from. The
JRC report clearly states that for a substance to be iden-
tified as an endocrine disrupter, evidence not only of an
endocrine mode-of-action but also of an adverse effect
is required, as well as some plausible link between
mode-of-action and adversity. This is consistent with
the widely accepted IPCS definition [11] of endocrine
disrupters which the JRC report accepted.
Concerning assays or endpoints that would be considered
adequate for assessments of evidence of adverse effects, the
JRC report makes detailed reference to level 4 or level 5 of
the assays included in the OECD Conceptual Framework
for the assessment of endocrine disrupters. This framework
is the result of expert efforts over many years [12]. Although
many endpoints relevant to endocrine disruption are not
included in the OECD study guidelines, the tests that
form part of the current framework are validated, robust,
reproducible methods that have been tested in many
laboratories before approval to ensure consistent, valid
results that are also recognised worldwide under the
OECD Mutual Acceptance of Data. These can hardly
be qualified as “irrelevant tests” as Dietrich et al. [5]
have done.
A priori assumption of human relevance
Referring to a statement by the European Commission
(again not referenced) that “relevance of the data to
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ate data demonstrating non-relevance”, Dietrich et al. [5]
declare: “The mere statement demonstrates the lack of
attention paid by the European Commission to the
weight of scientific evidence that clearly demonstrates
the presence of a threshold for non-genotoxic com-
pounds including EDC”. Here, the authors conflate the
statistical impossibility of demonstrating the absence of
effects (and thresholds) with the issue of demonstrating
human relevance of toxicity data derived from testing on
animals. In doing so they reveal ignorance of important
risk assessment principles elaborated in an IPCS Frame-
work document [11] for assessing the human relevance
of non-cancer endpoints [13]. The default assumption
under that framework is of human relevance, unless
there is evidence of toxicodynamic or toxicokinetic dif-
ferences between the animal test species and humans
that shows that the effect seen in animals is not
expected to occur in humans. The applicability of that
default assumption was tested through a number of case
studies [13]. The alternative a priori assumption (that ef-
fects seen in animals are not relevant for humans) would
be unworkable and would undermine the sense of
conducting toxicological testing in animals at all.
“Scientifically unfounded precaution”, and the
distinction between hazard assessment and risk
management
The most worrying aspect of the editorial by Dietrich
et al. [5] is the blurring of the border between what con-
stitutes science and what belongs to the realm of polit-
ical, societal and democratic choices.
The Precautionary Principle is enshrined in European
Law in the EC Treaty as well as in International Law
[14]. This principle was elaborated at the 1992 Rio Con-
ference on the Environment and Development, during
which the Rio Declaration was adopted. Principle 15
states that: “in order to protect the environment, the
precautionary approach shall be widely applied by States
according to their capability. Where there are threats of
serious or irreversible damage, lack of full scientific cer-
tainty shall not be used as a reason for postponing cost-
effective measures to prevent environmental degrad-
ation” [14]. Defined in this way, the precautionary
principle is a legal concept for addressing scientific un-
certainty, and not a scientific concept. Its interpretation
and application is a matter for politicians and lawyers.
The state of the science on endocrine disruption has
been reviewed and summarised in several recent reports
published by the UNEP/WHO or commissioned by the
European Commission [1,2,8,15]. Already over 10 years
ago, it was concluded that the state of the science justi-
fied regulatory action [13]. Decisions as to what kind of
action may be justified by the level of available evidenceand proportionate to the potential risks is a matter for
politicians and risk managers, and not the exclusive do-
main of scientists. Yet Dietrich et al. [5] express strong
reservations regarding the application of EU law but do
not engage with the scientific basis for concern, or with
widely published scientific evidence.
In contrast, the JRC report [8] made a clear distinction
between hazard identification and characterisation on
the one hand, which they considered within the remit of
their expertise, and risk management on the other.
Scientific truths about endocrine disruption as a
phenomenon resulting from disturbances of the pro-
gramming effects of the endocrine system during devel-
opment seem to have been ignored by Dietrich et al. [5].
It is to be hoped that this editorship of international
toxicological journals will be able to engage in a better
founded scientific debate which may help to overcome
a polarisation of views detrimental to reaching a con-
sensus about scientific foundations for endocrine dis-
rupter regulation in the EU.
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